日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot study

马拉利西巴治疗成人原发性硬化性胆管炎的安全性、耐受性和有效性：开放标签试点研究

期刊:Hepatology Communications
影响因子:4.6
doi:10.1097/HC9.0000000000000153
Bowlus, Christopher L; Eksteen, Bertus; Cheung, Angela C; Thorburn, Douglas; Moylan, Cynthia A; Pockros, Paul J; Forman, Lisa M; Dorenbaum, Alejandro; Hirschfield, Gideon M; Kennedy, Ciara; Jaecklin, Thomas; McKibben, Andrew; Chien, Elaine; Baek, Marshall; Vig, Pamela; Levy, Cynthia
发表日期：2023
文献求助 收藏

Maralixibat for the treatment of PFIC: Long-term, IBAT inhibition in an open-label, Phase 2 study

Maralixibat 用于治疗 PFIC：一项开放标签的 II 期研究的长期 IBAT 抑制研究

期刊:Hepatology Communications
影响因子:4.6
doi:10.1002/hep4.1980
Loomes, Kathleen M; Squires, Robert H; Kelly, Deirdre; Rajwal, Sanjay; Soufi, Nisreen; Lachaux, Alain; Jankowska, Irena; Mack, Cara; Setchell, Kenneth D R; Karthikeyan, Palaniswamy; Kennedy, Ciara; Dorenbaum, Alejandro; Desai, Nirav K; Garner, Will; Jaecklin, Thomas; Vig, Pamela; Miethke, Alexander; Thompson, Richard J
发表日期：2022
文献求助 收藏

Multitracer stable isotope quantification of arginase and nitric oxide synthase activity in a mouse model of pseudomonas lung infection

利用多示踪稳定同位素定量分析铜绿假单胞菌肺部感染小鼠模型中精氨酸酶和一氧化氮合酶的活性

期刊:Mediators of Inflammation
影响因子:4.2
doi:10.1155/2014/323526
Grasemann, Hartmut; Jaecklin, Thomas; Mehl, Anne; Huang, Hailu; Rafii, Mahroukh; Pencharz, Paul; Ratjen, Felix
炎症/感染
发表日期：2014
文献求助 收藏